Tan, Lianmei http://orcid.org/0000-0002-1445-4375
Yin, Tao
Xiang, Handan http://orcid.org/0000-0001-7957-7336
Wang, Liuyang
Mudgal, Poorva
Chen, Junying
Ding, Yi
Wang, Guoping
Lim, Bryan Jian Wei http://orcid.org/0000-0002-6048-2609
Huang, Yuqi http://orcid.org/0000-0002-3060-8418
Huang, De
Liang, Yaosi http://orcid.org/0000-0002-3478-0864
Alexander, Peter B.
Xiang, Kun http://orcid.org/0000-0001-7793-4352
Wang, Ergang http://orcid.org/0000-0003-2550-3686
Yan, Chengsong
Ma, Zhehao
Tan, Minjia http://orcid.org/0000-0002-6784-9653
Li, Qi-Jing http://orcid.org/0000-0002-0542-9784
Wang, Xiao-Fan http://orcid.org/0000-0001-7875-3940
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01-CA233205)
Article History
Received: 26 March 2024
Accepted: 24 September 2024
First Online: 3 October 2024
Competing interests
: Q.-J.L. is a scientific co-founder and shareholder of TCRCure Biopharma and Hervor Therapeutics. The other authors declare no competing interests.